Coronary artery occlusion is associated with the risk of ventricular remodelling, heart failure, and cardiogenic shock. Novel strategies are sought to treat these ominous complications. We examined the effect of a pericardial-derived fat flap secured over an acute infarct caused by coronary occlusion.
Introduction
Rapid and complete reperfusion of the blocked artery following acute myocardial infarction (MI) is critical to minimize myocardial necrosis and optimize cardiac repair.
1 Therapies to lyse the blood clot 2 and revascularize the stenotic arteries 3, 4 are effective treatments for acute MI. Nevertheless, frequently before reperfusion can be achieved or even arterial revascularization has been accomplished, cell necrosis initiates a process of adverse ventricular remodelling, leading to chamber dilatation, contractile dysfunction, and eventually cardiogenic shock. 5, 6 Cardiogenic shock complicates 7 -10% of cases of acute MI and is associated with a 70-80% mortality rate. 7 Novel therapeutic approaches for this condition are actively sought.
To improve cardiac function recovery after infarction, engineered heart tissue 8 -10 , or autologous vascularized tissue flaps may be effective techniques to limit tissue damage. Omentum flaps have been applied to heal anastomoses considered at risk for dehiscence, 11 and the transposition of latissimus dorsi covering the left ventricle has been tested in patients with refractory heart failure. 12 In this study, we transposed a pericardial-derived adipose flap over an infarct-related coronary artery region in pigs. Here, we provide 'proof of principle' evidence of histological and functional benefit, as well as the potential mechanisms of pericardial adipose flap-aided myocardial salvage after acute coronary occlusion.
Methods
This study was approved by the Animal Experimentation Unit Ethical Committee of the Catalan Institute of Cardiovascular Sciences (ICCC) and complies with all guidelines concerning the use of animals in research and teaching as defined by the Guide For the Care and Use of Laboratory Animals (NIH Publication No. 80-23, revised 1996).
Myocardial infarction model
For this study, 52 female crossbreed Landrace X Large White pigs (30-40 kg) were premedicated with azaperone (10 mg/kg, IM; Stresnil w , Laboratorios Dr Esteve, Barcelona, Spain) followed by pentobarbital sodium (15 mg/kg, IV; Tiobarbital w 1 g, B.Braun, Barcelona, Spain). Animals underwent endotracheal intubation, and anaesthesia was maintained by 2% isoflurane inhalation. Fentanyl (0.75 mg/kg/45 min, IV; Fentanest w , Kern Pharma, Barcelona, Spain) and a 1.5 mg/kg atracurium besylate bolus (Tracrium w , GlaxoSmithKline, London, UK) were given during intervention. Acute MI was induced by a double-ligation (Prolene 5/0 W8556 12-S, Ethicon, Inc., Sommerville, NJ, USA) of the first marginal branch of the circumflex artery, 1.5 cm distal from the atrioventricular groove. Transposition of pericardial adipose flap was performed in the treated group within 30 min after MI induction. In control-MI animals, excision and removal of pericardium and fat preceded coronary occlusion. Tulatromicin (2.5 mg/kg, IM; Draxxin w , Pfizer Animal Health, Madrid, Spain) was administered at the end of the intervention and a transdermal fentanyl patch was applied to allow analgesic post-operative care (Durogesic w , Janssen-Cilag, Madrid, Spain). All surgical procedures were done under monitoring conditions with ECG registration and measures of capnography, pulse oximetry, non-invasive arterial blood pressure and temperature.
Animals were randomly distributed into 6-day (n ¼ 6 control-MI and n ¼ 7 treated) or 1-month (n ¼ 17 control-MI and n ¼ 16 treated) groups after MI. A subgroup of 1-month pigs (n ¼ 7 control-MI and n ¼ 6 treated) underwent magnetic resonance imaging (MRI) at multiple time points (baseline, 2 h and 1 month after MI) to assess functional recovery. Three additional control-sham pigs (no MI induction) were sacrificed at 1 month to account for related fat flap changes.
Pericardial-derived adipose flap intervention
Under sterile conditions, thoracotomy was performed on the fourth left intercostal space to expose the heart, initially covered by the pericardium and pericardial fat ( Figure 1A) . Using dissection scissors, the pericardial adipose tissue was easily detached, maintaining its vascularization to create the adipose flap ( Figure 1B and C) . Then, the pericardium was partially excised and the outer surface of the cardiac chambers exposed. After 30 min of MI induction ( Figure 1D) , myocardium in the affected region became reddish purple and pericardial adipose flap was gently displaced, to fully cover the ischaemic zone ( Figure 1E ). To secure the flap, edges were sealed to the myocardial healthy zones using 0.1-0.2 mL of cyanoacrylic-based surgical glue (co-monomer of N-butyl-2-cyanoacrylate and metacryloxysulpholane; Glubran w 2, Cardiolink, Barcelona, Spain) ( Figure 1F ). Figure 1G -K schematically illustrates the sequence of events involved during the pericardial fat flap intervention.
MRI
Cardiac MRI was performed at 1.5 T (Intera, Philips, Best, The Netherlands) using a phased-array cardiac coil by investigators blinded to the treatment arm. All images were acquired in apnoea with ECG gating.
Morphometric, histological, and immunohistochemical analysis
After being premedicated, all animals were sacrificed with an intravenous injection of potassium chloride solution. Left ventricular (LV) infarct size was blindly measured in digitally photographed transverse heart sections from 1 cm distally to coronary ligation. Biopsies from infarct core, infarct border and remote myocardium were taken and fixed in 10% buffered formalin or flash frozen in liquid nitrogen. Masson's Trichrome was performed for the primary histological examination. A polarized light microscope was used to measure collagen types I and III on randomly selected Sirius redstained sections from both infarct core and remote zones. 13 Vessel area was blindly assessed by measuring Isolectin-B4-stained (Vectors Labs, Peterborough, UK) vessels in infarct core, border, and remote zones from Day 6 and 1-month groups. Moreover, vessel area within the fat flap was analysed: adipose tissue covering the infarct and that in contact with healthy myocardium. Apoptosis was analysed in infarct core and border zones from 6-day group, using an in situ cell death detection kit (Roche Diagnostics, Barcelona, Spain). Quantitative morphometric and histological measurements were completed with Image-Pro Plus software (6.2.1 version; Media Cybernetics, Inc., Bethesda, MD, USA).
Microarray gene expression and analysis
To detect changes in gene expression profile due to pericardial adipose flap intervention, 36 paired tissue samples from both groups were analysed: infarct core, remote zone, pericardial flap from treated animals, and pericardial adipose tissue from control-MI. Here, we compared gene expression in control-MI pericardial adipose tissue and transposed flap from treated animals both at 6 days and at 1 month after intervention. Moreover, we analysed gene expression in myocardial infarct tissue from control-MI and treated animals at both indicated time points. Microarray expression profiles were obtained using the Affymetrix GeneChip w Porcine Genome Array (Affymetrix, Santa Clara, CA, USA). Briefly, 200 ng of total RNA from each sample was processed, labelled, and hybridized to GeneChip w according to the Affymetrix GeneChip w 3 ′ IVT Express Kit User Manual. For functional analysis, lists of differentially regulated probe sets were uploaded into the Ingenuity Pathway Analysis online tool (IPA 8.0, Ingenuity System, Inc., www.ingenuity.com).
Statistical analysis
Data are presented as mean + SEM. All analyses were performed with SPSS (15.0.1 version, SPSS, Inc., Chicago, IL, USA). Differences between groups were compared using Student's t-test or one-way ANOVA for multiple comparisons, with Tukey's test for the post hoc analysis. MRI data were analysed as repeated measures using ANOVA with the Greenhouse-Geisser correction. Values of P , 0.05 were considered significant. Microarray data analysis was performed using R and Bioconductor, with an RMA-normalization and non-specific filtering, and limma (linear models for microarray data) package with the false discovery rate correction for the detection of differentially expressed genes.
Results
Six out of 52 infarcted pigs died during MI induction (4 due to ventricular fibrillation and 2 asystole). No atrial or ventricular arrhythmias were detected during intervention in surviving animals. In all treated pigs, cardiac examination upon sacrifice showed the fat flap covering the infarct area. Serial blood samples were obtained for cardiac biomarkers to measure acute myocardial damage. Remarkably, no significant differences in the circulating levels of cardiac troponin I (cTnI) and myoglobin were found between treated and control-MI animals (0.9 + 0.2 vs. 0.7 + 0.3 mg/L, P ¼ 0.56; and 451.7 + 101.2 vs. 425.3 + 87.7 mg/L, P ¼ 0.85, respectively).
Ventricular function
Baseline left ventricular ejection fraction (LVEF) was similar between groups (P ¼ 0.49). In control-MI, no significant changes were found between 2 h and 1 month (P ¼ 0.24) (Supplementary material online, Table S2 ). In contrast, the LVEF increased from 38.9 + 5.1% post-MI to 57.7 + 3.4% before euthanasia in treated animals (P , 0.001). The LVEF improvement was five-fold higher in treated compared with control-MI animals (18.8 + 6.3 vs. 4.1 + 6.2%; P ¼ 0.007) ( Figure 2A ). Delayed enhancement images, acquired before sacrifice, confirmed infarct size was substantially smaller in treated pigs ( Figure 2B ).
Analysis of ventricular volumes also showed a beneficial remodelling effect in the adipose flap group. In treated animals, end-systolic volume (ESV) significantly decreased between post-MI and 1 month without significant changes over time in end-diastolic volume (EDV) (Supplementary material online, Table S2 ). In control-MI pigs, ESV showed tendency to increase and EDV significantly increased between 2 h and 1 month due to adverse LV remodelling (see Supplementary material online, Table S2 ). Comparison between groups showed significant volume differences over time (29.1 + 6.6 vs. 4.6 + 5.6 mL; P ¼ 0.009 and 29.1 + 8.5 vs. 4.2 + 7.4 mL; P ¼ 0.03, for ESV and EDV in treated vs. control-MI, respectively) ( Figure 2C and D) . 
Scar maturation and collagen content
A set of experiments was done to analyse gross histopathological changes (n ¼ 33 pigs). Thirteen swine were euthanized 6 days after MI. In control-MI animals, myocardial necrosis involved nearly the full thickness of the ventricular wall in all cases with abundant red blood cell extravasation ( Figure 3A) . Light microscopy revealed loss of cross striations with appearance of focal hyalinization and interstitial tissue oedema ( Figure 3E) . In contrast, all treated animals developed non-transmural infarcts ( Figure 3B ), and only one had scattered zones of macroscopic haemorrhage. Histologically, less oedema and a greater amount of salvaged myocardial tissue was observed in treated animals ( Figure 3F ). Morphometry revealed that LV infarct area was significantly smaller in treated compared with control-MI pigs (5.1 + 1.4 vs. 12.9 + 3.6%; P ¼ 0.018) ( Figure 3I) .
At 1-month after MI a layer of viable subendocardium (that derives its oxygen directly from the ventricular cavity) was often present in all animals ( Figure 3C and D) . The necrotic muscle fibres and extravasated red cells were dissolved. At this stage, the infarcted area converted into a firm connective tissue scar in control-MI animals ( Figure 3G ). Interspersed intact muscle fibres were found more abundantly and LV infarct area was smaller in treated pigs (4.4 + 2.3 vs. 7.7 + 3%; P ¼ 0.049) ( Figure 3H and J ).
Collagen content was measured in infarct core and remote myocardium ( Figure 4A-E) . On Day 6 after MI, collagen volume fraction (CVF) at the infarct core was 2.4 + 0.4% in treated and 7.5 + 0.5% in control-MI pigs (P , 0.001). Collagen type III accounted for only 7% of extracellular matrix in control-MI group while it rose up to 33% of total collagen in treated animals. At the remote myocardium, CVF was 0.4 + 0.1% in treated and 1.8 + 0.6% in control-MI pigs (P ¼ 0.014) ( Figure 4E) . After 1 month, the mature fibrous scar characteristics were similar among groups (CVF: 53.7 + 14.5 vs. 43.8 + 13.2%; P ¼ 0.67; collagen type I: 91.4 + 10.8 vs. 87.9 + 10.8%; P ¼ 0.96; and collagen type III: 8.6 + 10.8 vs. 12.1 + 10.8%; P ¼ 0.96).
Vascular connections in the flap-myocardium boundary
We studied whether vascularization processes participated in the benefit obtained by the adipose flap. As early as 6 days after treatment, lectin-positive microvessels connecting the vascular flap with the underlying myocardium became apparent ( Figure 5A and B) . Remarkably, in control-sham pigs (fat flap applied on top on noninfarcted myocardium) these connections were not identified (data not shown). Interestingly, the flap intimately contacting the acutely ischaemic myocardium became intensely vascularized. Vessel area at the flap increased eight-fold compared with unstimulated fat (flap edges covering healthy myocardium) (2.4 + 0.9 vs. 0.3 + 0.2%; P , 0.001) ( Figure 5C-E) . In myocardial tissue samples, comparison of the control-MI and treated group revealed no differences in vessel density in infarct, remote, and border zones at 6 days (P ¼ 0.92, P ¼ 0.57, and P ¼ 0.33, respectively) and after 1 month (P ¼ 0.3, P ¼ 0.18, and P ¼ 0.55, respectively).
Increased vascular supply might enhance cell viability. Here, we found at Day 6, a significant reduction in apoptotic cells in the infarct border zone of animals receiving the flap treatment (18 + C. Gálvez-Montó n et al. 20 vs. 64 + 17%; P , 0.001) ( Figure 5F and G). Within the infarct core, a very limited number of cells undergoing apoptosis were identified in both treated ( Figure 5I ) and control-MI ( Figure 5H ) animals (24 + 27 vs. 12 + 16%; P ¼ 0.4) ( Figure 5J ).
Gene expression analysis
Finally, we analysed mRNA expression at 6-day and 1-month groups. Of 11 265 annotated genes interrogated, 81 genes showed differential regulation by the treatment in at least one condition ( Figure 6A and B). In the pericardial adipose tissue at Day 6, 13 unique regulated genes were increased and 10 were decreased; at 1 month, 2 unique regulated genes were increased and 13 were decreased; moreover, 10 of the 38 total regulated genes in adipose tissue were altered on both 6-day and 1-month groups ( Figure 6A ; Supplementary material online, Table S1A-C). Remarkably, all 10 of these common genes, which correspond mostly with transcripts encoding acute phase response proteins, were up-regulated on Day 6 and down-regulated at 1 month (Supplementary material online, Table S1B ).
To elucidate which adipokines might participate in the beneficial effect exerted by the flap, we analysed the expression pattern of 56 adipose tissue-related target genes. Comparing stimulated vs. nonstimulated flap, we found 19 related genes interrogated in microarray data, most of them up-regulated (FGF-2, IGF-1, VEGF, TGFB3, TF, IL-18, a2-macroglobulin, VCAM-1, ICAM-1, fibronectin, lysyl oxidase, and apelin). Additionally, we only detected VEGF expression by immunohistochemistry in the stimulated-pericardial adipose flap (see Supplementary material online, Figure S1 ). In infarct core tissue, 15 unique regulated genes were detected on Day 6; 5 were up-regulated and the remaining down-regulated ( Figure 6B ; Supplementary material online, Table S1D ). At 1 month, 18 unique regulated genes were detected; the majority of them was down-regulated and only 2 were increased ( Figure 6B ; Supplementary material online, Table S1E ). No common genes were found at the two studied time points in infarct core tissue.
Furthermore, IPA identified top genes and functions, and canonical pathways associated with the differentially expressed genes for each comparison analysed. Interestingly, in pericardial adipose tissue, early transcriptional response on Day 6 was dominated by up-regulation of genes involved in cell cycle progression, cellular growth and proliferation, and angiogenesis and blood vessel development ( Figure 6C ). In addition, those involved in cellular movement and inflammatory response were also up-regulated ( Figure 6C ).
Discussion
In this study, we examined the effect of a vascular adipose flap wrapped around oxygen-deprived myocardium in the porcine model. Our data show that a vascularized adipose flap, isolated from the pericardial surface, exerts beneficial effects on LV function. These effects may be partly explained by at least three mechanisms: First, LV volumes were smaller in treated animals, mainly due to reduction in the infarct scar by the flap, and also by direct effects Vascular fat flap to limit infarct size on the collagen network of the heart. Second, vascular communications developed between the transposed adipose flap and the recipient ischaemic bed. Finally, the former might contribute to cell survival in the infarct border after implantation.
Current techniques used to salvage infarcted myocardium rely on the revascularization of the major epicardial coronary arteries. 3, 4 However, the adverse prognosis of cardiogenic shock resulting from acute MI remains a major challenge for cardiologists and have been a few efforts to indirectly revascularize the ischaemic heart, including the simple insertion of the internal mammary artery into a hole made in ischaemic myocardium 15 or transmyocardial perforation with lasers to allow perfusion of the ischaemic myocardium, mimicking the sinusoids seen in reptilian hearts. 16 Unfortunately, these methods were either unsuccessful or successful only in selected patients with particular categories of disease. Dynamic cardiomyoplasty using latissimus dorsi muscle was developed to treat congestive heart failure. 17 However, long-term clinical data showed only modest benefit and skeletal muscle fatigue secondary to chronic continuous electrical stimulation. In recent years, there has been a totally innovative approach to surgical treatment of failing myocardium by implanting a mesh wrap around the heart (Acorn CorCap devices). 18 Despite the promise, the early enthusiasm has been tempered in light of preliminary clinical data. Indirect revascularization of damaged organs, by means of vascular grafts, has been achieved with more accomplishment. 19, 20 Our investigation shows new microvessels develop to bridge the interface between adjacent adipose tissue and ischaemic myocardium. In control-sham animals these vascular connections were not found, thus, demonstrating that tissue injury and hypoxia appear to be strong stimuli for the formation of such collaterals. The temporal stages of blood vessel development have been well described. 21 We already found microvessels on Day 6 after MI at the interface between the pericardial-derived adipose flap and the acutely ischaemic myocardium. Several studies suggest that the invasion of new blood vessels into various tissues occurs within 2 -7 days, 22, 23 and the time course of angiogenesis in this model is consistent with Vascular fat flap to limit infarct size those studies. This newly developed collateral circulation may improve local oxygen tension at the flap-myocardium boundary and decrease myocardial tissue hypoxia. Studies of myocardial samples from patients who died from acute MI show typical apoptotic myocytes, mainly in the border zone of the infarcted myocardium. 24, 25 In the present study, we provided further evidence demonstrating that the fat flap intervention improved cardiac function parameters, particularly ejection fraction, and significantly decreased infarct size. These findings in the treated group could be explained by an ischaemic myocardial cell death reduction, as shown in a subgroup of pigs sacrificed early 6 days after coronary artery ligation. The increment in contractility observed by pericardial adipose flap intervention is far greater than that obtained with other strategies such as stem cell therapy and tissue engineering. A recent meta analysis of 18 studies and 999 patients concluded that the available evidence suggests bone marrow cell transplantation is associated only with modest improvements in physiological and anatomical parameters (pooled LVEF difference 3.7%). 26 The development of engineered heart tissue for cardiac repair is evolving at a quick pace, yet several important questions remain for its potential clinical application, such as the use of autologous cells with cardiogenic potential and graft immunogenicity. 8, 10 Moreover, these engineered approaches have been tested in small rodents with limited benefit in terms of global increase in ejection fraction parameters. 9 Here, we propose an alternative approach using autologous pericardial adipose tissue as a vascularized and biological membrane. In our model, mean global LVEF increased by 19% in the adipose flap group and 4% in the control group. Most importantly, our data were obtained in the swine post-infarction model, the animal model with the highest similarity to the human heart in size and physiology. 27 Many studies have described the myocardium and perivascular adipose tissue as well-known sources of hormones, which might exert important autocrine, paracrine, and endocrine effects. 28 Such hormones might participate in the early beneficial role of the flap, yet in this study we have not been able to obtain temporal tissue samples in a day to day basis to confirm such effects. However, evidence accumulates that adipose-derived hormones can offer cardioprotective effects against ischaemia, including attenuation of cardiomyocyte apoptosis, reduction in infarct size, and modulation of collagen I/III ratio. 29 Our results indicate an up-regulation of the potent angiogenic factor VEGF accompanied by hypervascularization only in the infarctstimulated adipose flap. This is consistent with up-regulation of angiogenic and blood vessel development genes found in the stimulated pericardial adipose flap and with the appearance of vascular communications at the flap-myocardium boundary. We hypothesized that secreted VEGF by adipose tissue has an autocrine effect promoting angiogenesis within the flap. Moreover, a paracrine effect of VEGF in infarcted myocardium might activate the pro-survival Erk 1/2 cascade conferring cardioprotection. 30 Using polarized light, we were able to detect changes in the structural organization of collagen during scar maturation. The finding of both type I and type III collagen in the scar is consistent with other work on wound healing. 31 The increased amount of type III collagen is typical of the healing process, and the presence of type III fibres is an important feature for subsequent laying down of type I fibres. In animals covered by the adipose flap, we identified more type III fibres at Day 6. The mechanism by which the flap modulates scar maturation remains elusive; however, modulation of the collagen network may have important implications in the beneficial effect observed by the flap. Myocardial remodelling after infarction is characterized by a change in the proportion of collagens I and III, with an increase in the I/III ratio. 32 Type III collagen provides the framework for the alignment of type I fibres, essential to maintain the shape and contribute to the passive and active stiffness of the myocardium, 33 thus limiting remodelling of the ventricular chambers. Indeed, in our functional experiments, we found less remodelling and less gadolinium retention in treated animals. Pericardial adipose flap intervention altered gene expression in both myocardial infarct tissue and in the transposed adipose tissue, but only 81 genes appear to be differentially regulated. This may be partially explained by the P cut-off criterion which balances sensitivity and specificity in microarray studies. 34 In this study, common altered genes between remote myocardium and infarct core zones were discarded, as well as common genes among healthy adipose tissue and non-treated adipose tissue (control-MI) and/or treated flap. Therefore, our results highlight those genes significantly altered by the treatment irrespective of the infarction itself. Remarkably, in pericardial adipose tissue we found up-regulation of genes involved in angiogenesis and blood vessel development, a finding consistent with the hypervascularization of the stimulated flap and with the appearance of vascular communications at the flapmyocardium boundary. Coronary artery revascularization is the most effective treatment for acute MI, and all other approaches to salvage myocardium, including the present intervention, may only be considered when revascularization (either by percutaneous or surgical means) is not feasible. One major drawback of this pericardial-derived fat flap intervention, in terms of potential clinical applications, is the need for thoracotomy to gain access to the heart. The use of thoracoscopy for controlled dissection and transposition of the flap would be ideal.
In conclusion, transposition of a pericardial-derived adipose flap exerts beneficial effects on LV function after acute MI in the swine model. The application of a vascularized adipose flap limits LV remodelling, by means of reducing the infarct size and improving cell survival mediated by an enhanced vascular supply. Although we neither observed nor expected complete reversal of myocardial dysfunction after flap engraftment, we believe our study can serve as a proof of principle for a vascular flap approach to salvage cardiac muscle in acute MI.
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